Profile data is unavailable for this security.
About the company
STERIS Plc is a provider of products and services that support patient care with an emphasis on infection prevention. Its segments include Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. Its Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites. AST segment supports medical device and pharmaceutical manufacturers through a global network of contract sterilization and laboratory testing facilities, and integrated sterilization equipment and control systems. Its Life Sciences segment provides a comprehensive offering of products and services designed to support biopharmaceutical and medical device research and manufacturing facilities, in particular those focused on aseptic manufacturing. Its portfolio includes a full suite of consumable products, equipment maintenance, specialty services, and capital equipment.
- Revenue in USD (TTM)5.14bn
- Net income in USD551.44m
- Incorporated2016
- Employees18.18k
- LocationSTERIS plcBlock a Riverside IV70 Sir John Rogerson's QuayDUBLIN 2IrelandIRL
- Phone+353 12322000
- Websitehttps://www.steris.com/
Mergers & acquisitions
Acquired company | STE:NYQ since announced | Transaction value |
---|---|---|
Becton Dickinson & Co-Surgical Instrumentation Assets | 6.20% | 540.00m |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Insulet Corp | 1.78bn | 234.00m | 12.71bn | 3.00k | 56.48 | 16.07 | 41.20 | 7.14 | 3.21 | 3.21 | 23.61 | 11.29 | 0.7249 | 1.36 | 6.62 | 593,566.70 | 9.53 | 2.71 | 11.42 | 3.14 | 68.86 | 65.81 | 13.14 | 4.28 | 2.75 | 65.58 | 0.6393 | 0.00 | 30.02 | 24.66 | 4,384.78 | 128.77 | -7.63 | -- |
Baxter International Inc | 14.89bn | -38.00m | 17.37bn | 60.00k | -- | 2.12 | 13.90 | 1.17 | -0.0762 | 5.21 | 29.33 | 16.04 | 0.5311 | 3.21 | 5.71 | 248,200.00 | -0.107 | 0.1942 | -0.1338 | 0.2333 | 36.31 | 38.20 | -0.2015 | 0.3674 | 1.01 | 3.58 | 0.625 | 1,398.94 | 2.12 | 5.94 | 97.15 | -- | 0.982 | 9.71 |
Hologic Inc | 3.96bn | 466.50m | 17.39bn | 6.99k | 38.34 | 3.59 | 22.15 | 4.39 | 1.94 | 1.94 | 16.30 | 20.76 | 0.4361 | 2.66 | 5.82 | 566,609.40 | 5.14 | 11.40 | 5.74 | 13.38 | 55.12 | 60.29 | 11.78 | 20.95 | 3.29 | -- | 0.3465 | 0.00 | -17.12 | 4.61 | -64.98 | -- | 7.30 | -- |
Cooper Companies Inc | 3.73bn | 339.90m | 18.83bn | 15.00k | 68.49 | 2.42 | 26.07 | 5.05 | 1.38 | 1.38 | 10.69 | 39.19 | 0.3164 | 1.71 | 5.95 | 248,766.70 | 2.88 | 10.06 | 3.13 | 11.34 | 66.23 | 65.54 | 9.11 | 29.00 | 1.14 | 4.98 | 0.258 | 0.3469 | 8.61 | 7.24 | -23.74 | -3.66 | 15.18 | 31.95 |
Align Technology, Inc. | 3.92bn | 462.28m | 19.16bn | 21.61k | 41.93 | 5.10 | 31.84 | 4.89 | 6.07 | 6.07 | 51.44 | 49.94 | 0.6497 | 3.96 | 4.27 | 181,237.60 | 7.67 | 16.34 | 11.51 | 24.14 | 70.06 | 71.72 | 11.80 | 23.16 | 1.09 | -- | 0.00 | 0.00 | 3.42 | 14.45 | 23.09 | 2.15 | -4.46 | -- |
Steris PLC | 5.14bn | 551.44m | 22.59bn | 18.18k | 41.07 | 3.58 | 20.19 | 4.40 | 5.56 | 3.81 | 51.79 | 63.73 | 0.4696 | 4.26 | 5.31 | 282,672.40 | 5.06 | 5.19 | 5.51 | 5.68 | 43.17 | 43.64 | 10.77 | 10.97 | 2.36 | 6.75 | 0.3367 | 36.56 | 13.28 | 13.06 | -1.07 | 12.67 | 13.69 | 8.83 |
Zimmer Biomet Holdings Inc | 7.45bn | 963.80m | 23.27bn | 18.00k | 24.49 | 1.85 | 12.10 | 3.12 | 4.62 | 4.62 | 35.72 | 61.24 | 0.3491 | 0.9052 | 5.27 | 414,027.80 | 4.52 | 2.21 | 5.14 | 2.52 | 71.89 | 71.25 | 12.95 | 7.28 | 0.802 | 7.32 | 0.315 | 38.90 | 6.55 | -1.40 | 252.86 | -- | 9.44 | 0.00 |
West Pharmaceutical Services Inc. | 2.93bn | 568.70m | 23.95bn | 10.60k | 43.34 | 8.95 | 34.52 | 8.18 | 7.58 | 7.58 | 39.09 | 36.72 | 0.7995 | 4.20 | 5.65 | 276,283.00 | 15.08 | 15.61 | 17.99 | 18.65 | 37.15 | 38.06 | 18.86 | 18.47 | 1.95 | -- | 0.0714 | 10.69 | 2.18 | 11.43 | 2.28 | 23.76 | 28.16 | 6.20 |
Resmed Inc | 4.58bn | 958.38m | 30.47bn | 10.14k | 31.92 | 6.58 | 26.76 | 6.65 | 6.50 | 6.50 | 31.07 | 31.52 | 0.6777 | 2.20 | 5.99 | 452,086.70 | 14.17 | 13.59 | 15.98 | 15.89 | 55.78 | 56.98 | 20.91 | 19.22 | 1.97 | 25.88 | 0.1786 | 36.66 | 18.02 | 12.53 | 15.15 | 14.63 | 13.40 | 4.68 |
Holder | Shares | % Held |
---|---|---|
The Vanguard Group, Inc.as of 31 Mar 2024 | 11.42m | 11.55% |
BlackRock Fund Advisorsas of 31 Mar 2024 | 5.80m | 5.87% |
Massachusetts Financial Services Co.as of 31 Mar 2024 | 5.66m | 5.73% |
WCM Investment Management LLCas of 31 Mar 2024 | 4.74m | 4.79% |
SSgA Funds Management, Inc.as of 31 Mar 2024 | 4.12m | 4.17% |
APG Asset Management NVas of 31 Mar 2024 | 3.73m | 3.78% |
Morgan Stanley Investment Management Ltd.as of 31 Mar 2024 | 2.79m | 2.83% |
Geode Capital Management LLCas of 31 Mar 2024 | 2.25m | 2.27% |
Generation Investment Management LLPas of 31 Mar 2024 | 2.14m | 2.17% |
Janus Henderson Investors US LLCas of 31 Mar 2024 | 1.99m | 2.01% |